Annual Drug Patent Expirations for ZOMIG
Zomig is a drug marketed by Astrazeneca and IPR and is included in three NDAs. It is available from one supplier. There are two patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for ZOMIG.
The generic ingredient in ZOMIG is zolmitriptan. One supplier is listed for this compound. Additional details are available on the zolmitriptan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com